The Structure of ChAdOx1/AZD-1222 Reveals Interactions with CAR and PF4 with Implications for Vaccine-induced Immune Thrombotic Thrombocytopenia
暂无分享,去创建一个
Chun Kit Chan | Eric A. Wilson | P. Fromme | M. Borad | A. Singharoy | P. Rizkallah | M. Heurich | Daipayan Sarkar | A. Parker | C. Truong | E. Bates | Dewight R Williams | J. Vant | Ryan J Boyd | E. Wilson | A. T. Baker | Po-Lin Chiu | M. Lipka-Lloyd | M. Nagalo | Kasim Waraich | A. T. Crespo | Ryan J. Boyd
[1] M. Schull,et al. Vaccine-Induced Immune Thrombotic Thrombocytopenia (VITT) Following Adenovirus Vector COVID-19 Vaccination: Lay Summary , 2021 .
[2] K. McCrae. Thrombotic thrombocytopenia due to SARS-CoV-2 vaccination. , 2021, Cleveland Clinic journal of medicine.
[3] T. Renné,et al. Towards Understanding ChAdOx1 nCov-19 Vaccine-induced Immune Thrombotic Thrombocytopenia (VITT) , 2021 .
[4] S. Koepsell,et al. Thrombotic Thrombocytopenia after Ad26.COV2.S Vaccination , 2021, The New England journal of medicine.
[5] Andreas Greinacher,et al. Thrombotic Thrombocytopenia after ChAdOx1 nCov-19 Vaccination , 2021, The New England journal of medicine.
[6] S. Eichinger,et al. A Prothrombotic Thrombocytopenic Disorder Resembling Heparin-Induced Thrombocytopenia Following Coronavirus-19 Vaccination , 2021 .
[7] T. Stehle,et al. Human species D adenovirus hexon capsid protein mediates cell entry through a direct interaction with CD46 , 2020, Proceedings of the National Academy of Sciences.
[8] G. Koh. Faculty Opinions recommendation of Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK , 2020, Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature.
[9] Nguyen H. Tran,et al. Safety and efficacy of the ChAdOx1 nCoV-19 vaccine (AZD1222) against SARS-CoV-2: an interim analysis of four randomised controlled trials in Brazil, South Africa, and the UK , 2020, Lancet.
[10] Nguyen H. Tran,et al. Safety and immunogenicity of ChAdOx1 nCoV-19 vaccine administered in a prime-boost regimen in young and old adults (COV002): a single-blind, randomised, controlled, phase 2/3 trial. , 2020, Lancet.
[11] Conrad C. Huang,et al. UCSF ChimeraX: Structure visualization for researchers, educators, and developers , 2020, Protein science : a publication of the Protein Society.
[12] Yi Wang,et al. Scalable molecular dynamics on CPU and GPU architectures with NAMD. , 2020, The Journal of chemical physics.
[13] J. M. de la Rosa-Trevín,et al. Localized reconstruction in scipion expedites the analysis of symmetry mismatches in Cryo-EM data. , 2020, Progress in biophysics and molecular biology.
[14] P. Rizkallah,et al. Human adenovirus type 26 uses sialic acid–bearing glycans as a primary cell entry receptor , 2019, Science Advances.
[15] Simon C. Potter,et al. The EMBL-EBI search and sequence analysis tools APIs in 2019 , 2019, Nucleic Acids Res..
[16] Erik Lindahl,et al. New tools for automated high-resolution cryo-EM structure determination in RELION-3 , 2018, eLife.
[17] P. Rizkallah,et al. Diversity within the adenovirus fiber knob hypervariable loops influences primary receptor interactions , 2018, Nature Communications.
[18] A. Parker,et al. Designer Oncolytic Adenovirus: Coming of Age , 2018, Cancers.
[19] Torsten Schwede,et al. SWISS-MODEL: homology modelling of protein structures and complexes , 2018, Nucleic Acids Res..
[20] Tristan Ian Croll,et al. ISOLDE: a physically realistic environment for model building into low-resolution electron-density maps , 2018, Acta crystallographica. Section D, Structural biology.
[21] Markus Heinonen,et al. Flex ddG: Rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation , 2017, bioRxiv.
[22] Markus Heinonen,et al. Flex ddG: Rosetta ensemble-based estimation of changes in protein-protein binding affinity upon mutation , 2017, bioRxiv.
[23] R. Sun,et al. Atomic Structures of Minor Proteins VI and VII in Human Adenovirus , 2017, Journal of Virology.
[24] M. Parsons,et al. CAR: A key regulator of adhesion and inflammation. , 2017, The international journal of biochemistry & cell biology.
[25] Jiahui Chen,et al. Improvements to the APBS biomolecular solvation software suite , 2017, Protein science : a publication of the Protein Society.
[26] A. Greinacher,et al. Anti-platelet factor 4/polyanion antibodies mediate a new mechanism of autoimmunity , 2017, Nature Communications.
[27] D. Veesler,et al. Cryo-EM structure of human adenovirus D26 reveals the conservation of structural organization among human adenoviruses , 2017, Science Advances.
[28] C. Maffeo. Atomic Resolution Brownian Dynamics , 2016 .
[29] B. L. de Groot,et al. CHARMM36m: an improved force field for folded and intrinsically disordered proteins , 2016, Nature Methods.
[30] Klaus Schulten,et al. Molecular dynamics-based refinement and validation for sub-5 Å cryo-electron microscopy maps , 2016, eLife.
[31] R. Stanton,et al. Incorporation of Peptides Targeting EGFR and FGFR1 into the Adenoviral Fiber Knob Domain and Their Evaluation as Targeted Cancer Therapies , 2015, Human gene therapy.
[32] T. Kurosaki,et al. Memory B cells , 2015, Nature Reviews Immunology.
[33] Taco G. Uil,et al. Manipulating Adenovirus Hexon Hypervariable Loops Dictates Immune Neutralisation and Coagulation Factor X-dependent Cell Interaction In Vitro and In Vivo , 2015, PLoS pathogens.
[34] Yang Zhang,et al. The I-TASSER Suite: protein structure and function prediction , 2014, Nature Methods.
[35] Peter Ortoleva,et al. Epitope fluctuations in the human papillomavirus are under dynamic allosteric control: a computational evaluation of a new vaccine design strategy. , 2013, Journal of the American Chemical Society.
[36] B. Kuhlman,et al. A comparison of successful and failed protein interface designs highlights the challenges of designing buried hydrogen bonds , 2013, Protein science : a publication of the Protein Society.
[37] Sjors H.W. Scheres,et al. RELION: Implementation of a Bayesian approach to cryo-EM structure determination , 2012, Journal of structural biology.
[38] A. Parker,et al. Ad5:Ad48 hexon hypervariable region substitutions lead to toxicity and increased inflammatory responses following intravenous delivery. , 2012, Molecular therapy : the journal of the American Society of Gene Therapy.
[39] Alexander D. MacKerell,et al. Optimization of the additive CHARMM all-atom protein force field targeting improved sampling of the backbone φ, ψ and side-chain χ(1) and χ(2) dihedral angles. , 2012, Journal of chemical theory and computation.
[40] Shaoxia Chen,et al. Prevention of overfitting in cryo-EM structure determination , 2012, Nature Methods.
[41] K. Bojang,et al. A Novel Chimpanzee Adenovirus Vector with Low Human Seroprevalence: Improved Systems for Vector Derivation and Comparative Immunogenicity , 2012, PloS one.
[42] I. Tanaka,et al. Crystal structure of the receptor binding domain , 2011 .
[43] D. Barouch,et al. Adenovirus Serotype 5 Neutralizing Antibodies Target both Hexon and Fiber following Vaccination and Natural Infection , 2011, Journal of Virology.
[44] M. Othman,et al. Human platelets express CAR with localization at the sites of intercellular interaction , 2011, Virology Journal.
[45] J. García de la Torre,et al. Prediction of hydrodynamic and other solution properties of rigid proteins from atomic- and residue-level models. , 2011, Biophysical journal.
[46] D. Henaff,et al. Coagulation factor X mediates adenovirus type 5 liver gene transfer in non-human primates (Microcebus murinus) , 2011, Gene Therapy.
[47] V. Kähäri,et al. Requirements for Receptor Engagement during Infection by Adenovirus Complexed with Blood Coagulation Factor X , 2010, PLoS pathogens.
[48] L. Rauova,et al. Role of the platelet chemokine platelet factor 4 (PF4) in hemostasis and thrombosis. , 2010, Thrombosis research.
[49] N. Van Rooijen,et al. Effect of Neutralizing Sera on Factor X-Mediated Adenovirus Serotype 5 Gene Transfer , 2008, Journal of Virology.
[50] Leonardo G. Trabuco,et al. Flexible fitting of atomic structures into electron microscopy maps using molecular dynamics. , 2008, Structure.
[51] J. Marshall. Coming of age. , 2008, Surgical infections.
[52] C. Verlinde,et al. Identification of CD46 Binding Sites within the Adenovirus Serotype 35 Fiber Knob , 2007, Journal of Virology.
[53] R. Powell,et al. Heparin induced thrombocytopenia: diagnosis and management update , 2007, Postgraduate Medical Journal.
[54] Hisham S. Elbatarny,et al. Adenovirus-induced thrombocytopenia: the role of von Willebrand factor and P-selectin in mediating accelerated platelet clearance. , 2007, Blood.
[55] Y. Liu,et al. Adenovirus-Platelet Interaction in Blood Causes Virus Sequestration to the Reticuloendothelial System of the Liver , 2007, Journal of Virology.
[56] Olivier Billet,et al. Structural and Mutational Analysis of Human Ad37 and Canine Adenovirus 2 Fiber Heads in Complex with the D1 Domain of Coxsackie and Adenovirus Receptor* , 2006, Journal of Biological Chemistry.
[57] Kevin Cowtan,et al. research papers Acta Crystallographica Section D Biological , 2005 .
[58] O. Danos,et al. Canine Adenovirus Type 2 Attachment and Internalization: Coxsackievirus-Adenovirus Receptor, Alternative Receptors, and an RGD-Independent Pathway , 2000, Journal of Virology.
[59] K Schulten,et al. VMD: visual molecular dynamics. , 1996, Journal of molecular graphics.
[60] J Deisenhofer,et al. Crystal structure of the receptor-binding domain of adenovirus type 5 fiber protein at 1.7 A resolution. , 1994, Structure.
[61] Therése L. Eriksson,et al. The GD1a glycan is a cellular receptor for adenoviruses causing epidemic keratoconjunctivitis , 2011, Nature Medicine.
[62] W. Delano. The PyMOL Molecular Graphics System , 2002 .
[63] R. Morgan,et al. Toxicity of a first-generation adenoviral vector in rhesus macaques. , 2002, Human gene therapy.